Background: The long-term results of Tricuspid Valve Replacement (TVR) depend on factors related to the original valve disease more than on the prosthesis type. Tricuspid valve prosthesis; either mechanical or bioprosthetic, should be chosen according to the individual patient's characteristics.
Introduction
HISTORICALLY, Tricuspid Valve (TV) surgery has been associated with high operative mortality and morbidity and considered a marker for endstage valvular heart disease [1] . When the anatom-ical abnormality of the TV leaflets is severe, Tricuspid Valve Replacement (TVR) is necessary [3] , especially in re-operations on highly deformed valves and in the case of a second or third intervention performed for residual or recurrent Tricuspid Regurgitation (TR) [2] . Currently, right sided valve replacement might be considered for patients with only mild symptoms [2] , avoiding the high mortality risk associated with right ventricular dilatation in late intervention [3] . The outcome of TV surgery is less predictable than that of other valves; with higher risk and a worse outcome than the mitral valve replacements, because of the complex anatomy and late repeated interventions [2] . The durability of mechanical heart valves leads to low rates of re-operation, compared with that of bio-prosthetic valves. But, mechanical valve dysfunction (nonstructural), such as prosthetic leaflet restriction due to thrombus or pannus formation and para-valvular leak, has been problematic [4] . There is insufficient data to determine which valve prosthesis is better for tricuspid valve replacement [я . The objective of this meta-analysis is to compare the outcomes of TVR using mechanical versus bioprosthetic valves in the studies published in 20 years.
Material and Methods
We identified relevant studies published in the past 20 years (1995 to 2015), through Embase, PubMed, Ovid, Science Direct, Wiley Blackwell and Justin and we included related articles found through manual search. The data were reviewed by the 1 st and 2 nd authors followed by the third one to confirm that the studies meet the inclusion criteria. The text strings used were formatted for PubMed as 1-(Tricuspid valve disease) 2-AND 3-(Tricuspid valve replacement) 4-AND 5-(Mechanical-OR-Bioprosthetic) or ((Mechanical) then (Bioprosthetic)). To further reduce the probability of losing any major related study, all references of included studies were evaluated. Data extraction was conducted independently by two authors and a third one if there is a discrepancy in the collected data.
According to the pre-set strict criteria "intrainstitutional comparison between the outcomes of bioprosthetic and mechanical tricuspid valve in adult patients" relevant papers in English were selected from the search result. The exclusion criteria were: Studies that have no direct comparison between the bioprosthetic and the mechanical valve studies that do not report the outcomes and studies that were produced at the same institution and there was a sample overlap, in this case, the most updated study was included.
After excluding non-relevant studies, we found 17 studies comparing the two valves. We found 1724 from search and related articles, after removal of duplicates, 1505 studies remained. From them, 1319 were excluded: 1189 irrelevant studies, 10 of percutaneous TVR, 23 of tricuspid valve repair, 58 before 1995 or after 2015, 26 including children, infants, and neonates, ten not in English, 2 of cadavers, and 1 in cardiac transplantation patients. Then we fully assessed 186 studies to include 17 and exclude 169: 25 of population less than 10 patients,1 study was repeated with the same institution data, 104 abstract, editorial, conference papers, and not enough supplied data, 9 did not discuss morbidity, 5 studies on mechanical valves only, 9 on bioprosthetic tricuspid valve only, 16 studies on TVR with no data comparison Fig 
Statistical analysis:
Forest plots were used to summarize the results of each outcome. The effect size is shown as a square, and its size is related and proportionate to the weight of each study. Black diamond presents the pooled effect size which indicates the overall results. If it lies completely at one side of the solid central vertical line without crossing it, this indicates significant results [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Statistical significance was set at a p-value of 0.05 or less.
Funnel plots were used to asses publication bias, and the dots around the central vertical line have to be distributed in an equal way on both sides to exclude publication bias [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
The endpoints were postoperative morbidity including; valve thromboses, emboli, heart block, bleeding, low cardiac output, infective endocarditis, valve failure, stroke, and renal failure.
All analyses were performed using RevMan (Version 5.3. Copenhagen: The Nordic Cochrane Centre, the Cochrane Collaboration, 2014).
Results

Study summary:
Database research yielded 17 studies meeting the inclusion criteria and reporting an institutional comparison between the tricuspid bioprosthetic valve and the mechanical valve. These studies are presenting the outcome of 1020 mechanical and 1199 bioprosthetic valve. Studies are summarized in (Table 1 ) which shows the date of publication, number of patients, the time range of the operation and geographical distribution of the studies.
Post-operative thrombosis:
Fourteen studies compared thrombosis with mechanical Vs. bioprosthetic valve, all of them favored the bioprosthetic valve, and our metaanalysis revealed the significantly lower risk of thrombosis with bioprosthetic valve, and there is no publication bias (Pooled RR=6.52; 95% CI: 3.00-14.15 and p-value >0.001) Figs. (2A, 3) .
Post-operative valve failure:
Twelve studies compared valve failure in patients receiving bioprosthetic Vs. mechanical valve, 9 of them favored the mechanical valve and three favored bioprosthetic valve. Our meta-analysis revealed insignificant difference between the both valves with no publication bias (Pooled RR=0.51; 95% CI: 0.25-1.04 and p-value=0.07) Figs. (2B, 4) .
Post-operative embolic events:
Post-operative embolic events were presented by five studies comparing mechanical and bioprosthetic valve from which 4 favored the bioprosthetic valve and one favored the mechanical valve. Our results showed that bioprosthetic valve has significant better outcome (Pooled RR=2.25; 95% CI: 1.14-4.46 and p-value=0.02) Fig. (5) .
Post-operative stroke and cerebrovascular events:
Six studies reported post-operative stroke, and cerebrovascular events, 4 of them favored the mechanical valve and 2 favored the bioprosthetic valve, our meta-analysis revealed insignificant difference for both valves (Pooled RR=0.63; 95% CI: 0.22-1.80 and p-value=0.39) Fig. (6) .
Post-operative infective endocarditis:
Five studies compared infective endocarditis between both valves (mechanical and bioprosthetic), 2 of them favored the mechanical valve while 3 favored the bioprosthetic valve. Our meta-analysis revealed no significant difference was between the both valves (Pooled RR=1.09; 95% CI: 0.35-3.39 and p-value=0.89).
Post-operative low cardiac output:
Five studies compared post-operative low cardiac output in mechanical Vs. bioprosthetic tricus-pid valves, 2 supported the mechanical valve, and 3 supported the bioprosthetic valve. Our metaanalysis revealed insignificant difference between both valves (Pooled RR=0.95; 95% CI: 0.62-1.45 and p-value=0.82).
Post-operative atrioventricular block:
Four studies compared post-operative atrioventricular block in mechanical and bioprosthetic tricuspid valves, all of them supported the mechanical valve, but no significant difference was found Pooled RR=0.61 (95% CI: 0.25-1.50 and p-value= 0.279).
Post-operative renal failure:
Post-operative renal dysfunction was reported in 4 studies 2 of them favored the mechanical valve and 2 favored the bioprosthetic valve, and there was the non-significant difference between both valves (Pooled RR=0.73 (95% CI: 0.38-1.39 and p-value=0.42).
Post-operative bleeding:
Post-operative bleeding was reported by nine studies from which 5 showed better results with the mechanical valve and 4 showed better results with the bioprosthetic valve, and our meta-analysis showed a statistically non-significant difference for the two valves (Pooled RR=0.96; 95% CI: 0.51-1.81 and p=0.91). 
Discussion
Tricuspid valve repair is the first option in tricuspid valve surgery [24] . When repair is not feasible, and tricuspid valve replacement becomes mandatory, the question which prosthesis is better in this tricuspid position is still debatable. No optimum valve substitute is available and comparing tricuspid bioprosthesis and mechanical valves; each one has its advantages and disadvantages. Recent guidelines in the management of the valvular heart disease stated that not enough evidence of the superiority of one valve over the other [25] .
Bioprosthetic valves were considered the best choice for tricuspid valve replacement as anticoagulation is not needed, and degeneration is expected on a more extended period than the mitral valves due to the low right side pressure. However, some studies reported short durability of the bioprosthetic valves and determination occurred in less than nine years [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] , and some were associated with pannus formation [27, 28] . While studies proved the new bi-leaflets mechanical valves function in low gradient with optimum durability [11] .
We did a meta-analysis study to compare the outcome and post-operative morbidity following mechanical and bioprosthetic tricuspid valves. These data were presented by studies comparing the two group of patients under the same postoperative care and in the same institution.
For post-operative valve thrombosis, in general, the tricuspid valve is bigger than a mitral, and aortic valve with low velocity across it increases the risk of thrombosis. All the 14 studies showed better outcome with the bioprosthetic valve, which justifies the rationale of most of the surgeons preferring bioprosthetic valve, and that is explained by the high risk of thrombosis with mechanical valve when the INR is below therapeutic level [22, 23] and reported with multiple redo cases [22] and some of them required re-replacement [21] . The same for post-operative embolic events, the majority of the studies (4 of 5) favored the bioprosthetic valve, which could be explained by the high risk of thrombosis with the mechanical valve [22, 23] even with anticoagulation treatment [18] . Several factors could affect the incidence of embolic events, such as ventricular function, valve position, rhythm, prosthetic valve type, coagulation status, and patient compliance [19] . But infective endocarditis either early or late was nearly the same in both groups, even though thrombosis is significantly more with the mechanical valve [8, 22, 23] . Infective endocarditis increased the incidence of reoperation [8] [9] [10] [11] [12] [13] [14] and increased mortality [7] [8] [9] [10] [11] .
On the other side, the majority of the studies (9 of 12) showed better postoperative valve failures results with the mechanical valve, and that's related to its longer durability as compared to the bioprosthetic valve [13] [14] [15] [16] [17] [18] [19] . Mechanical valve failure was due to pannus formation, and the paravalvular leak which was reported more frequently with the mechanical valves [19, 29] . These complications make the bioprosthetic valve the valve of choice if no other indications necessitate the insertion of mechanical valve like concomitant anticoagulation therapy.
Post-operative stroke and cerebrovascular presented as cerebral infarction [13] [14] [15] [16] [17] [18] [19] , stroke [2, 7, 13, 19, 21] and mostly related to short periods of perioperative hypoperfusion or patients' related risk factor which could occur with both valve types [19] . Other complications including atrioventricular block, renal failure, low cardiac output, and bleeding occurred equally in both valve types with no significant difference. Causes of death following TVR were a progressive myocardial failure and acute pulmonary edema [7, 13, 21] , bleeding and reoperation [2, 7, 13, 21] and renal failure requiring dialysis [13, 21] .
Study strength and limitations:
The study contributes to the clinician knowledge to which TV prosthesis to choose for their patients based on literature evidence during 20 years. All the included studies are retrospective which presents a study limitation; however, no available randomized trial comparing valve types in the literature due to the infrequency of the procedure.
Conclusion:
The choice of the prosthesis in tricuspid valve replacement depends on the risk factors of the patient as each type of prosthesis has its own risk and complications. Re-operation, bleeding, valve failure, infective endocarditis, cerebrovascular events, low cardiac output, AV block, and renal failure didn't differ significantly between the two types. Bioprosthetic valve is a significantly lower risk of thrombosis and embolism. So, when the choice of the prosthesis is equivocal, the bioprosthetic valve should be preferred because of its less morbidity.
